Dr. Reddy’s Laboratories gets Health Canada nod for generic Semaglutide injection
Dr. Reddy’s Laboratories has achieved a significant milestone by securing a Notice of Compliance from Health Canada for its generic Semaglutide injection. File photo: Special Arrangement Dr. Reddy’s Laboratories has received a Notice of Compliance (NOC) from Health Canada for its generic Semaglutide Injection. It has become the first company to receive the market authorisation…
Read More “Dr. Reddy’s Laboratories gets Health Canada nod for generic Semaglutide injection” »
